Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Third Harmonic Bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +40 vs. Q2 2022
- Shares held
- 35.5M
- +35.5M vs. Q2 2022
- Total value
- $672.8M
- +$672.8M vs. Q2 2022
- New holders
- 40
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $110.0K |
| Q1 2026 | 4 | $110.0K |
| Q4 2025 | 4 | $111.5K |
| Q3 2025 | 18 | $1.19M |
| Q2 2025 | 107 | $210.2M |
| Q1 2025 | 100 | $134.4M |
| Q4 2024 | 98 | $462.5M |
| Q3 2024 | 85 | $596.6M |
| Q2 2024 | 77 | $523.2M |
| Q1 2024 | 71 | $357.6M |
| Q4 2023 | 62 | $416.0M |
| Q3 2023 | 56 | $241.5M |
| Q2 2023 | 48 | $173.5M |
| Q1 2023 | 49 | $149.7M |
| Q4 2022 | 50 | $153.1M |
| Q3 2022 | 40 | $672.8M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Third Harmonic Bio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $206.9M | 22.83% | +10,907,859 | New |
| OrbiMed Advisors LLC | 5,779,071 | $109.6M | 2.18% | +5,779,071 | New |
| BVF Inc | 3,501,814 | $66.4M | 2.74% | +3,501,814 | New |
| Ra Capital Management, L.P. | 3,475,687 | $65.9M | 1.41% | +3,475,687 | New |
| General Atlantic LLC | 2,958,762 | $56.1M | 0.66% | +2,958,762 | New |
| Bain Capital Life Sciences Investors, LLC | 2,280,082 | $43.3M | 5.16% | +2,280,082 | New |
| Deep Track Capital, LP | 1,268,220 | $24.1M | 1.19% | +1,268,220 | New |
| Wellington Management Group LLP | 1,168,554 | $22.2M | 0.00% | +1,168,554 | New |
| Commodore Capital LP | 1,018,569 | $19.3M | 3.11% | +1,018,569 | New |
| RTW Investments, LP | 609,687 | $11.6M | 0.27% | +609,687 | New |
| Boxer Capital, LLC | 570,417 | $10.8M | 0.61% | +570,417 | New |
| Price T Rowe Associates Inc | 470,626 | $8.93M | 0.00% | +470,626 | New |
| Woodline Partners LP | 200,063 | $3.79M | 0.06% | +200,063 | New |
| Artal Group S.A. | 200,000 | $3.79M | 0.20% | +200,000 | New |
| Suvretta Capital Management, LLC | 200,000 | $3.79M | 0.16% | +200,000 | New |
| Millennium Management LLC | 178,301 | $3.38M | 0.00% | +178,301 | New |
| Vanguard Group Inc | 100,000 | $1.90M | 0.00% | +100,000 | New |
| Alyeska Investment Group, L.P. | 75,000 | $1.42M | 0.02% | +75,000 | New |
| Marshall Wace, LLP | 58,465 | $1.11M | 0.00% | +58,465 | New |
| Citadel Advisors LLC | 57,687 | $1.09M | 0.00% | +57,687 | New |
| Goldman Sachs Group Inc | 54,500 | $1.03M | 0.00% | +54,500 | New |
| Monashee Investment Management LLC | 40,000 | $759.0K | 0.28% | +40,000 | New |
| Ghisallo Capital Management LLC | 40,000 | $759.0K | 0.10% | +40,000 | New |
| Barclays PLC | 28,750 | $546.0K | 0.00% | +28,750 | New |
| Qube Research & Technologies Ltd | 27,800 | $527.0K | 0.00% | +27,800 | New |
| Squarepoint Ops LLC | 25,384 | $482.0K | 0.00% | +25,384 | New |
| Two Sigma Investments, LP | 25,000 | $474.0K | 0.00% | +25,000 | New |
| Manufacturers Life Insurance Company, The | 20,766 | $391.2K | 0.00% | +20,766 | New |
| Point72 Hong Kong Ltd | 19,099 | $362.0K | 0.02% | +19,099 | New |
| Jane Street Group, LLC | 18,809 | $357.0K | 0.00% | +18,809 | New |
| Platinum Investment Management Ltd | 17,825 | $338.0K | 0.01% | +17,825 | New |
| Caas Capital Management LP | 16,000 | $304.0K | 0.04% | +16,000 | New |
| Polar Asset Management Partners Inc. | 11,596 | $220.0K | 0.00% | +11,596 | New |
| Cubist Systematic Strategies, LLC | 10,561 | $200.0K | 0.00% | +10,561 | New |
| Eversept Partners, LP | 10,000 | $189.7K | 0.02% | +10,000 | New |
| Point72 Asset Management, L.P. | 8,000 | $152.0K | 0.00% | +8,000 | New |
| Morgan Stanley | 7,160 | $136.0K | 0.00% | +7,160 | New |
| Royal Bank of Canada | 5,557 | $105.0K | 0.00% | +5,557 | New |
| UBS Group AG | 1,252 | $24.0K | 0.00% | +1,252 | New |
| Sandia Investment Management LP | 1,000 | $19.0K | 0.00% | +1,000 | New |